Elsevier, a leading global provider of scientific information and data analytics, has been honored with the prestigious AI Innovation Award in the 8th annual MedTech Breakthrough Awards program. This accolade recognizes Elsevier’s groundbreaking innovation, ClinicalKey AI, which integrates advanced artificial intelligence (AI) capabilities into its renowned ClinicalKey platform to revolutionize healthcare delivery.
The MedTech Breakthrough Awards program, organized by MedTech Breakthrough, an independent market intelligence organization, aims to acknowledge the top companies, technologies, and products driving innovation in the global digital health and medical technology market. Elsevier’s ClinicalKey AI stood out among fierce competition, earning recognition for its transformative impact on clinical decision-making and patient care.
Developed in collaboration with OpenEvidence, ClinicalKey AI represents a fusion of trusted, evidence-based clinical content with cutting-edge AI technology. Leveraging generative AI-powered conversational search, ClinicalKey AI empowers clinicians to access high-quality patient care insights swiftly and efficiently.
A distinguishing feature of ClinicalKey AI is its ability to generate tailored responses to clinical queries by analyzing information from validated sources, including Elsevier’s proprietary point-of-care content, medical reference texts, journal abstracts, and government publications. These evidence-based responses include references with linked citations to supporting published evidence, ensuring clinicians have access to the most up-to-date and reliable information at their fingertips.
The mission of the MedTech Breakthrough Awards is to honor excellence and innovation across various health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), and Virtual Care. This year’s program attracted thousands of nominations from over 18 countries worldwide, underscoring the global impact of breakthrough technologies in healthcare.
Elsevier’s commitment to responsible AI is evident in ClinicalKey AI's development process, which involved rigorous testing by over 30,000 clinicians and continuous evaluation of accuracy by a team of over 100 clinicians and two health system development partners. Debuting with live demonstrations at HIMSS this year, ClinicalKey AI showcases the transformative potential of AI innovation in healthcare, supported by robust AI safeguards and trusted evidence-based content.
ClinicalKey AI enables clinicians to pose questions in natural language and receive rapid, accurate responses akin to consulting a trusted specialist. Its intuitive clinical reasoning assistant facilitates quick searches across a comprehensive base of clinical knowledge, while accounting for patient context such as comorbidities and medications. Furthermore, the solution offers personalized user profiles to enhance user experience and efficiency.
By empowering clinicians with comprehensive insights into disease conditions and treatment options, ClinicalKey AI not only enhances patient care but also fosters a culture of evidence-based practice within healthcare institutions. Hospital leaders can leverage ClinicalKey AI to drive cost-effective, patient-centric care delivery, thereby optimizing healthcare outcomes and experiences.
As Elsevier continues to spearhead innovation in healthcare, ClinicalKey AI stands as a testament to the transformative potential of AI-powered solutions in revolutionizing clinical decision-making and patient care delivery.
Click here to read the original press release.
